+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Glioma Treatment Market by Type of Glioma (High-grade Gliomas, Low-grade Gliomas), Treatment Type (Chemotherapy, Immunotherapy, Radiation Therapy), End-user, Distribution Channel - Forecast 2024-2030- Product Image
Global Glioma Treatment Market by Type of Glioma (High-grade Gliomas, Low-grade Gliomas), Treatment Type (Chemotherapy, Immunotherapy, Radiation Therapy), End-user, Distribution Channel - Forecast 2024-2030- Product Image
Sale

Global Glioma Treatment Market by Type of Glioma (High-grade Gliomas, Low-grade Gliomas), Treatment Type (Chemotherapy, Immunotherapy, Radiation Therapy), End-user, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968146
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Glioma Treatment Market size was estimated at USD 4.95 billion in 2023, USD 5.29 billion in 2024, and is expected to grow at a CAGR of 7.43% to reach USD 8.18 billion by 2030.

Glioma treatment refers to the various medical strategies used to manage and treat gliomas, a type of spinal cord and brain tumor. Gliomas are categorized based on the type of cells they develop from, their aggressiveness, and how fast they are likely to evolve and spread. In surgery, the primary goal is to remove as much of the tumor as possible without damaging surrounding healthy brain tissue. This can help reduce symptoms and improve outcomes. An increase in the global prevalence of gliomas due to genetic factors, environmental exposure, and lifestyle choices contributes directly to the growth of this market.

Intensive ongoing research aiming to understand tumor biology better and develop more effective treatment options fuels market expansion. However, the expense associated with advanced glioma therapies can be prohibitive, limiting access primarily to patients in developed countries. Stringent regulatory requirements for approving new drugs and therapies can delay product availability and impact market growth. Furthermore, innovations in medical imaging and neurosurgery have significantly improved the precision of tumor removal and post-operative recovery, posing substantial opportunities for advanced glioma treatments.

Regional Insights

In the Americas, glioma treatment includes a combination of surgery, radiation therapy, and chemotherapy, with significant emphasis on advanced treatment modalities such as tumor treatment fields (TTF). The region benefits from robust healthcare infrastructure, high healthcare spending, and access to cutting-edge medical technology. Institutions, including the National Institutes of Health (NIH) and private foundations, extensively support research and clinical trials. Consumer behavior in these countries shows high trust in healthcare systems, readiness to adopt new treatments, and significant influence of doctor recommendations on treatment choices.

European countries typically have well-established healthcare systems with equal access to glioma treatment. These nations invest heavily in healthcare R&D, translating to early adoption of innovative treatments. The EU framework promotes cross-border healthcare initiatives, facilitating significant research collaborations. This region presents a contrast, with countries including the UAE exhibiting advanced healthcare systems similar to Western standards. In contrast, many African countries face resource-limited settings impacting the availability and quality of glioma treatment. Asia Pacific is rapidly advancing in research and treatment offerings for glioma. China and Japan are important countries in the region, with strong governmental support for research and healthcare infrastructure. Japan’s aging population drives demand for effective glioma treatments, reflected in tailored healthcare services and products. India, while developing, projects a high growth potential due to improvements in healthcare infrastructure and increasing awareness about cancer treatment. General trends in Asia Pacific include a strong preference for branded medications and a growing openness to participating in clinical trials.

Market Trends by Segment

  • Treatment Type: Growing preference for radiation therapy for widespread and aggressive tumors due to its efficacy
  • End-user: Research institutes actively working on advancing glioma treatment and developing new therapeutic strategies

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Advancements in Glioma Characterization and Treatment Through TLX101-CDx PET Imaging Agent

The FDA's fast-track designation for TLX101-CDx, also known as Pixclara (18F-floretyrosine or 18F-FET), marks a significant step towards addressing the unmet needs in glioma diagnosis, particularly in distinguishing between tumor progression and treatment-induced changes.TLX101-CDx targets LAT1 and LAT2 membrane transport proteins, which could enhance its use as a diagnostic aid alongside TLX101, an investigational therapy primarily aimed at glioblastoma treatment.

MimiVax, Inc. Secures Strategic Investments to Advance SurVaxM in Glioblastoma Treatment

MimiVax, Inc. has secured funding from various venture philanthropy and investor groups, including the Brain Tumor Investment Fund, Sontag Innovation Fund, MEDA Angels, Varia Ventures, and additional private backers. These investments are earmarked for advancing the ongoing Phase 2b clinical trial, subsequent regulatory processes, and eventual commercialization stages of SurVaxM, a vaccine therapy aimed at treating newly diagnosed glioblastoma (ndGBM)

Rigel Pharmaceuticals, Inc. and CONNECT Join Forces to Advance Pediatric High-Grade Glioma Treatment Through Innovative Clinical Trial

Rigel Pharmaceuticals, Inc. has announced a significant partnership with CONNECT to initiate a Phase 2 clinical trial examining REZLIDHIA (olutasidenib) alongside temozolomide for maintenance therapy in youth with high-grade glioma exhibiting the IDH1 mutation. This trial incorporated Rigel Pharmaceuticals, Inc.'s commitment by contributing up to USD 3 million and providing necessary study substances over a four-year period. Specifically, the trial explored the efficacy of olutasidenib combined with temozolomide post-radiotherapy, transitioning into a maintenance phase with olutasidenib alone for patients under 39, including those suffering from diffuse intrinsic pontine glioma - a particularly challenging brain cancer with few current effective treatments.

Key Company Profiles

The report delves into recent significant developments in the Glioma Treatment Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., Azurity Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Emcure Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd, Intas Pharmaceuticals Ltd., Karyopharm Therapeutics Inc., Mayo Clinic, Merck & Co Inc., MimiVax, Inc., Pfizer Inc., Rigel Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., and Thermo Fisher Scientific Inc.

This research report offers invaluable insights into various crucial aspects of the Glioma Treatment Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of gliomas globally
5.1.1.2. Reforms and support initiatives for glioma treatment
5.1.2. Restraints
5.1.2.1. High cost of combination treatment
5.1.3. Opportunities
5.1.3.1. Advancements in precision medicine technologies
5.1.3.2. Collaborative R&D efforts aimed at discovering novel therapies for glioma
5.1.4. Challenges
5.1.4.1. Limited efficacy and side effects of current treatments
5.2. Market Segmentation Analysis
5.2.1. Treatment Type: Growing preference for radiation therapy for widespread and aggressive tumors due to its efficacy
5.2.2. End-user: Research institutes actively working on advancing glioma treatment and developing new therapeutic strategies
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Glioma Treatment Market, by Type of Glioma
6.1. Introduction
6.2. High-grade Gliomas
6.3. Low-grade Gliomas
7. Glioma Treatment Market, by Treatment Type
7.1. Introduction
7.2. Chemotherapy
7.3. Immunotherapy
7.4. Radiation Therapy
7.5. Targeted Therapy
8. Glioma Treatment Market, by End-user
8.1. Introduction
8.2. Hospitals
8.3. Research Institutes
8.4. Specialty Clinics
9. Glioma Treatment Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Local Pharmacies
9.4. Online Pharmacies
10. Americas Glioma Treatment Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Glioma Treatment Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Glioma Treatment Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Advancements in Glioma Characterization and Treatment Through TLX101-CDx PET Imaging Agent
13.3.2. MimiVax, Inc. Secures Strategic Investments to Advance SurVaxM in Glioblastoma Treatment
13.3.3. Rigel Pharmaceuticals, Inc. and CONNECT Join Forces to Advance Pediatric High-Grade Glioma Treatment Through Innovative Clinical Trial
13.3.4. Thermo Fisher and UCSF Collaborate on Advanced Cell Therapies Manufacturing for Oncological and Rare Diseases
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. GLIOMA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLIOMA TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GLIOMA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLIOMA TREATMENT MARKET DYNAMICS
FIGURE 7. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2023 VS 2030 (%)
FIGURE 8. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. GLIOMA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. GLIOMA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GLIOMA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GLIOMA TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL GLIOMA TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY HIGH-GRADE GLIOMAS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY HIGH-GRADE GLIOMAS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY LOW-GRADE GLIOMAS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY LOW-GRADE GLIOMAS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY LOCAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY LOCAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 65. CANADA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 66. CANADA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 67. CANADA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 68. CANADA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 69. CANADA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 70. CANADA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 71. CANADA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 72. CANADA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 73. MEXICO GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 74. MEXICO GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 75. MEXICO GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 76. MEXICO GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 77. MEXICO GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. MEXICO GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. MEXICO GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 80. MEXICO GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 101. AUSTRALIA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 102. AUSTRALIA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 109. CHINA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 110. CHINA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 111. CHINA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 112. CHINA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 113. CHINA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 114. CHINA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 115. CHINA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 116. CHINA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 117. INDIA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 118. INDIA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 119. INDIA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 120. INDIA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 121. INDIA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 122. INDIA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 123. INDIA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 124. INDIA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 125. INDONESIA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 126. INDONESIA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 133. JAPAN GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 134. JAPAN GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 135. JAPAN GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 136. JAPAN GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 137. JAPAN GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 138. JAPAN GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 139. JAPAN GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 140. JAPAN GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 141. MALAYSIA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 142. MALAYSIA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 149. PHILIPPINES GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 150. PHILIPPINES GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 157. SINGAPORE GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 158. SINGAPORE GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 165. SOUTH KOREA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 166. SOUTH KOREA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 173. TAIWAN GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 174. TAIWAN GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 181. THAILAND GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 182. THAILAND GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 183. THAILAND GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 184. THAILAND GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 185. THAILAND GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. THAILAND GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. THAILAND GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 188. THAILAND GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 189. VIETNAM GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 190. VIETNAM GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 207. DENMARK GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 208. DENMARK GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 209. DENMARK GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 210. DENMARK GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 211. DENMARK GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 212. DENMARK GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 213. DENMARK GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 214. DENMARK GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 215. EGYPT GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 216. EGYPT GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 217. EGYPT GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 218. EGYPT GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 219. EGYPT GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 220. EGYPT GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 221. EGYPT GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 222. EGYPT GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 223. FINLAND GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 224. FINLAND GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 225. FINLAND GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 226. FINLAND GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 227. FINLAND GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 228. FINLAND GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 229. FINLAND GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 230. FINLAND GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 231. FRANCE GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 232. FRANCE GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 233. FRANCE GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 234. FRANCE GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 235. FRANCE GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 236. FRANCE GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 237. FRANCE GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 238. FRANCE GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 239. GERMANY GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 240. GERMANY GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 241. GERMANY GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 242. GERMANY GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 243. GERMANY GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 244. GERMANY GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 245. GERMANY GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 246. GERMANY GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 247. ISRAEL GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 248. ISRAEL GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 255. ITALY GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 256. ITALY GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 257. ITALY GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 258. ITALY GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 259. ITALY GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 260. ITALY GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 261. ITALY GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 262. ITALY GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 263. NETHERLANDS GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 264. NETHERLANDS GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 271. NIGERIA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 272. NIGERIA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 279. NORWAY GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 280. NORWAY GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 281. NORWAY GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 282. NORWAY GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 283. NORWAY GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 284. NORWAY GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 285. NORWAY GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 286. NORWAY GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 287. POLAND GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 288. POLAND GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 289. POLAND GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 290. POLAND GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 291. POLAND GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 292. POLAND GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 293. POLAND GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 294. POLAND GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 295. QATAR GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 296. QATAR GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 297. QATAR GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 298. QATAR GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 299. QATAR GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 300. QATAR GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 301. QATAR GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 302. QATAR GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 303. RUSSIA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 304. RUSSIA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 305. RUSSIA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 306. RUSSIA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 307. RUSSIA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 308. RUSSIA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 309. RUSSIA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 310. RUSSIA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 312. SAUDI ARABIA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 314. SAUDI ARABIA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 316. SAUDI ARABIA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 318. SAUDI ARABIA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 320. SOUTH AFRICA GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 322. SOUTH AFRICA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 324. SOUTH AFRICA GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 326. SOUTH AFRICA GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 327. SPAIN GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 328. SPAIN GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 329. SPAIN GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 330. SPAIN GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 331. SPAIN GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 332. SPAIN GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 333. SPAIN GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 334. SPAIN GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 335. SWEDEN GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 336. SWEDEN GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 337. SWEDEN GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 338. SWEDEN GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 339. SWEDEN GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 340. SWEDEN GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 341. SWEDEN GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 342. SWEDEN GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 343. SWITZERLAND GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 344. SWITZERLAND GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2024-2030 (USD MILLION)
TABLE 345. SWITZERLAND GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 346. SWITZERLAND GLIOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 347. SWITZERLAND GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 348. SWITZERLAND GLIOMA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 349. SWITZERLAND GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 350. SWITZERLAND GLIOMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 351. TURKEY GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA, 2018-2023 (USD MILLION)
TABLE 352. TURKEY GLIOMA TREATMENT MARKET SIZE, BY TYPE OF GLIOMA,

Companies Mentioned

  • Amgen Inc.
  • Azurity Pharmaceuticals, Inc.
  • Bristol-Myers Squibb Company
  • Emcure Pharmaceuticals Ltd.
  • F. Hoffmann-La Roche Ltd
  • Intas Pharmaceuticals Ltd.
  • Karyopharm Therapeutics Inc.
  • Mayo Clinic
  • Merck & Co Inc.
  • MimiVax, Inc.
  • Pfizer Inc.
  • Rigel Pharmaceuticals Inc.
  • Sumitomo Dainippon Pharma Oncology Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.29 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.18 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Global Adult Malignant Glioma Therapeutics Market Analysis & Forecast to 2024-2034 - Product Image

Global Adult Malignant Glioma Therapeutics Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Glioma Treatment Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease, Treatment Type, Grade, End User, and Geography - Product Image

Glioma Treatment Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease, Treatment Type, Grade, End User, and Geography

  • Report
  • 182 Pages
  • Global
From
Glioma Treatment Global Market Report 2024 - Product Image

Glioma Treatment Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Adult Malignant Glioma Therapeutics Global Market Report 2024 - Product Image

Adult Malignant Glioma Therapeutics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Glioma Diagnosis and Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Glioma Diagnosis and Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 111 Pages
  • Global
From

About the Market

The Glioma Drug market is a subset of the larger Brain Cancer Drug market. Glioma is a type of brain cancer that is caused by the abnormal growth of glial cells in the brain. Treatment for glioma typically involves surgery, radiation therapy, chemotherapy, and targeted therapy. Drugs used to treat glioma include temozolomide, bevacizumab, and lomustine. Glioma drugs are typically used in combination with other treatments, such as radiation and surgery, to improve patient outcomes. The market for glioma drugs is expected to grow due to the increasing prevalence of brain cancer and the development of new treatments. Some companies in the Glioma Drug market include Novartis, Merck, Roche, and Pfizer. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.